Summit Therapeutics Inc.

SMMT

$17.83

Name : Summit Therapeutics Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $14,259,790,848.00

EPSttm : -1.06

Summit Therapeutics Inc.

$17.83

0.06%

$0.01

SMMT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

26.86

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

0.04

EPS Last/This Y

-0.33

EPS This/Next Y

Price

17.83

Target Price

29.99

Analyst Recom

1.59

Performance Q

18.08

Upside

-178.0%

Beta

-1.52

Ticker: SMMT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	SMMT	17.14	0.70	0.20	210006
2026-10-13	SMMT	15.53	0.69	0.25	213441
2026-10-14	SMMT	15.12	0.65	0.17	230321
2026-10-15	SMMT	15.36	0.62	0.53	239018
2026-10-16	SMMT	14.65	0.61	0.47	239631
2026-10-19	SMMT	15.59	0.62	0.39	207964
2026-10-20	SMMT	16.1	0.62	0.28	219835
2026-10-21	SMMT	15.82	0.61	1.14	224400
2026-10-22	SMMT	15.56	0.62	1.04	227952
2026-10-23	SMMT	15.47	0.63	0.26	230128
2026-10-26	SMMT	14.51	0.63	0.34	228359
2026-10-27	SMMT	15.34	0.64	0.43	232829
2026-10-28	SMMT	15.78	0.64	0.40	235662
2026-10-29	SMMT	16.2	0.63	0.10	236143
2026-10-30	SMMT	16.02	0.60	0.03	243775
2026-11-02	SMMT	14.8	0.56	0.24	243261
2026-11-03	SMMT	15.78	0.56	0.26	247888
2026-11-04	SMMT	16.18	0.56	0.16	251010
2026-11-05	SMMT	14.18	0.55	1.59	256873
2026-11-06	SMMT	16.34	0.64	0.32	272167
2026-11-09	SMMT	17.84	0.57	0.37	260348
2026-11-10	SMMT	17.82	0.58	0.56	265869
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	SMMT	17.15	7.4	-	-0.85
2026-10-13	SMMT	15.53	7.4	-	-0.85
2026-10-14	SMMT	15.12	7.4	-	-0.85
2026-10-15	SMMT	15.36	9.8	-	-0.84
2026-10-16	SMMT	14.65	9.8	-	-0.84
2026-10-19	SMMT	15.58	9.8	-	-0.84
2026-10-20	SMMT	15.58	9.8	-	-0.84
2026-10-21	SMMT	16.09	9.7	-	-0.84
2026-10-22	SMMT	15.56	9.7	-	-0.84
2026-10-23	SMMT	15.46	9.7	-	-0.84
2026-10-26	SMMT	14.51	9.7	-	-0.84
2026-10-27	SMMT	15.34	9.8	-	-0.84
2026-10-28	SMMT	15.78	9.8	-	-0.84
2026-10-29	SMMT	16.21	10.1	-	-0.84
2026-10-30	SMMT	16.03	10.1	-	-0.84
2026-11-02	SMMT	14.79	10.1	-	-0.84
2026-11-03	SMMT	15.80	10.1	-	-0.84
2026-11-04	SMMT	16.18	10.1	-	-0.84
2026-11-05	SMMT	14.18	10.1	-	-0.84
2026-11-06	SMMT	16.34	-20.2	-	-0.84
2026-11-09	SMMT	17.84	-20.2	-	-0.84
2026-11-10	SMMT	17.83	-1.8	-	-0.79
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	SMMT	1.23	12.32	27.02
2026-10-13	SMMT	1.23	12.32	27.02
2026-10-14	SMMT	1.23	12.32	27.02
2026-10-15	SMMT	1.23	12.32	27.02
2026-10-16	SMMT	1.23	12.32	27.02
2026-10-19	SMMT	1.23	12.42	27.02
2026-10-20	SMMT	1.23	12.42	27.03
2026-10-21	SMMT	1.23	12.42	27.03
2026-10-22	SMMT	1.23	12.42	27.03
2026-10-23	SMMT	1.23	12.42	27.03
2026-10-26	SMMT	1.23	12.55	27.03
2026-10-27	SMMT	1.23	12.55	26.86
2026-10-28	SMMT	1.23	12.55	26.86
2026-10-29	SMMT	1.23	12.55	26.86
2026-10-30	SMMT	1.23	12.55	26.86
2026-11-02	SMMT	1.23	12.71	26.86
2026-11-03	SMMT	1.23	12.71	26.86
2026-11-05	SMMT	1.23	12.71	26.86
2026-11-06	SMMT	1.23	12.71	26.86
2026-11-09	SMMT	1.23	10.15	26.86
2026-11-10	SMMT	1.23	10.15	26.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.22

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

1.23

Institutional Transactions

10.15

Beta

-1.52

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

51.7

Max Drawdown 5-Year %

-87.6

Target Price

29.99

P/E

Forward P/E

PEG

P/S

P/B

25.25

P/Free Cash Flow

EPS

-1.07

Average EPS Est. Cur. Y

-0.79

EPS Next Y. (Est.)

-0.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.72

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

◆ SMMT Healthcare

$17.83

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

6/25

Volume

9/15

Valuation

12/20

TP/AR

1/10

Options

4/10

RSI

58.7

Range 1M

87.9%

Sup Dist

8.1%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

16/25

Growth

14/30

Estimates

0/20

Inst/Vol

7/15

Options

7/10

EPS Yr

26.9%

EPS NY

3.9%

52W%

32.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +68.2% upside

Quality

2/30

Valuation

12/30

Growth

11/25

Stability

7/10

LT Trend

4/5

Upside

+68.2%

Quality

SMMT — P/E HistoricalBiotechnology

Summit Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 265

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

SMMT

Latest News

—

Caricamento notizie per SMMT…

stock quote shares SMMT – Summit Therapeutics Inc Stock Price stock today

news today SMMT – Summit Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SMMT – Summit Therapeutics Inc yahoo finance google finance

stock history SMMT – Summit Therapeutics Inc invest stock market

stock prices SMMT premarket after hours

ticker SMMT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SMMT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y